secwatch / observer
8-K filed November 6, 2024, 6:59 PM ET ticker HCAT CIK 0001636422
earnings confidence high sentiment positive materiality 0.70

Health Catalyst Q3 revenue $76.4M, Adj. EBITDA $7.3M; acquires Intraprise for $43M

Health Catalyst, Inc.

2024-Q3 EPS reported -$0.82 revenue$226,978,000

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jill Hoggard Green

Director
HCAT · Health Catalyst, Inc.
Effective
2024-12-01
Filed
November 6, 2024, 6:59 PM ET
On November 2, 2024, the board of directors (the “Board”) of the Company, upon the recommendation of the Nominating and Corporate Governance Committee, appointed Dr. Jill Hoggard Green to the Board, effective December 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jill Hoggard Green was appointed as Director at Health Catalyst, Inc..

Action
appointed
Role
Director
Exact text from the filing
On November 2, 2024, the board of directors (the “Board”) of the Company, upon the recommendation of the Nominating and Corporate Governance Committee, appointed Dr. Jill Hoggard Green to the Board, effective December 1, 2024.
View on SEC.gov

Health Catalyst, Inc. filing history →

Source: SEC EDGAR
accession 0001636422-24-000148
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.